IMVT Past Earnings image   This IMVT past earnings page last updated 11/7/2022
IMVT Past Earnings
PeriodPast Earnings DateGAAP
Q2 202311/4/2022-0.410
Q1 20238/5/2022-0.350
Q4 20226/8/2022-0.410
Q3 20222/4/2022-0.360
Q2 202211/5/2021-0.350
Q1 20228/9/2021-0.310
Q4 20216/1/2021-0.290
Q3 20212/16/2021-0.320
Q2 202111/12/2020-0.250
Q1 20218/12/2020-0.380
Q4 20206/29/2020-0.380
IMVT Past Revenue
PeriodPast Earnings DateGAAP
Q2 202311/4/2022NA
Q1 20238/5/2022NA
Q4 20226/8/2022NA
Q3 20222/4/2022NA
Q2 202211/5/2021NA
Q1 20228/9/2021NA
Q4 20216/1/2021NA
Q3 20212/16/2021NA
Q2 202111/12/2020NA
Q1 20218/12/2020NA
Q4 20206/29/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree IMVT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Immunovant (IMVT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

INAB Past Earnings
INBX Past Earnings
INCY Past Earnings
INDP Past Earnings
INFI Past Earnings
INGN Past Earnings
INMB Past Earnings
INNV Past Earnings
INO Past Earnings
INSM Past Earnings

IMVT Past Earnings Q&A

What was the best and worst IMVT past earnings results?
For Immunovant, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IMVT past earnings result in our data set was -0.250/share posted in Q2 2021, while the lowest was in Q2 2023 when IMVT posted -0.410/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2023 when IMVT reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2023 at NA of revenue.

  Suggested answer: There are 11 IMVT past earnings results in our data set.

On this page we presented the IMVT past earnings date information for Immunovant. Reviewing that IMVT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2021, when IMVT posted gaap of -0.250/share. Meanwhile the lowest IMVT past earnings result was in Q2 2023, when IMVT posted gaap of -0.410/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2023 when IMVT reported NA in revenue, while the smallest revenue quarter was Q2 2023 when IMVT reported NA in revenue.

Any self directed investor doing their due diligence on IMVT or any other given stock can benefit from researching all of the Immunovant past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Immunovant past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IMVT. Thanks for visiting, and the next time you need to research IMVT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: CHFC Videos, XTXI Split History, Institutional Holders of NBSE.

 

IMVT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.